1990
DOI: 10.1002/path.1711620408
|View full text |Cite
|
Sign up to set email alerts
|

Deduction from Wilms' tumour that glomerular podocytes produce the basement membrane material bearing goodpasture determinants

Abstract: Using an indirect immunoperoxidase technique, we tested frozen specimens from one Wilms' tumour composed of numerous glomeruloid bodies devoid of blood vessels, with monoclonal antibodies directed against vimentin, cytokeratin, CALLA/CD10, CD24, CR1/CD35, endothelium factor VIII, class I and II MHC molecules, laminin, fibronectin, and non-collagenic domain NC1 of type IV collagen. Two reagents against Goodpasture determinants were used: P1 monoclonal antibody and serum IgG (GP antibodies) from a biopsy-proven … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…27 Another study examined sections of Wilms tumor and showed that the avascular glomeruloid bodies were labeled with antibodies against Goodpasture determinants (previously shown to be structural motifs located specifically on the NC1 domain of the ␣3 chain of collagen IV), 16,28 providing additional evidence that this protein is a product of podocytes. 29 Although results from cultured immortalized podocytes need to be interpreted carefully, experiments have also shown that these cells synthesize ␣3(IV) collagen in vitro. For example, addition of exogenous vascular endothelial growth factor (VEGF) to immortalized mouse podocytes increases the production of collagen ␣3(IV), and this is reversed by treatment with the VEGF receptor inhibitor, SU5416.…”
Section: Discussionmentioning
confidence: 99%
“…27 Another study examined sections of Wilms tumor and showed that the avascular glomeruloid bodies were labeled with antibodies against Goodpasture determinants (previously shown to be structural motifs located specifically on the NC1 domain of the ␣3 chain of collagen IV), 16,28 providing additional evidence that this protein is a product of podocytes. 29 Although results from cultured immortalized podocytes need to be interpreted carefully, experiments have also shown that these cells synthesize ␣3(IV) collagen in vitro. For example, addition of exogenous vascular endothelial growth factor (VEGF) to immortalized mouse podocytes increases the production of collagen ␣3(IV), and this is reversed by treatment with the VEGF receptor inhibitor, SU5416.…”
Section: Discussionmentioning
confidence: 99%
“…Note that in rats CD10 is expressed on PECs, whereas in humans CD10 is expressed on podocytes and proximal tubules. 11,12 Narp protein was neither detected in monocytes/macrophages using ED1, nor in apoptotic cells using antibodies against active Caspase 3 (Figure 5e and f respectively).…”
Section: Identification Of Narp-positive Cells In Glomerulimentioning
confidence: 96%
“…Wilms tumor retains some features of the different steps of metanephric kidneys, including those of glomeruloid bodies similar to glomeruli 12,13 . Previous studies have shown that glomeruloid bodies in WMT express several markers for podocytes, including CALLA, CR1, and vimentin 14–17 16,17 .…”
mentioning
confidence: 98%
“…Previous studies have shown that glomeruloid bodies in WMT express several markers for podocytes, including CALLA, CR1, and vimentin 14–17 16,17 . However, the differentiation status of podocytes is better tested by examining the combined expression of recently identified specific markers for podocytes, such as WT1, synaptopodin or nephrin, and the functional structures such as foot processes or slit diaphragms 18–21 …”
mentioning
confidence: 99%